Schott Group plans to expand its global pharmaceutical glass tube production capacity in China

SCHOTT signed an investment agreement and plans to build a new medicinal glass tube production base in Zhejiang Province.

In order to meet the growing demand for high quality first-grade water-resistant medicinal glass tubes in China, SCHOTT will increase its support for the Chinese market. The company plans to invest in a new factory to produce FIOLAX® borosilicate glass tubes. . “The new glass tube base in Jinyun County, Zhejiang Province is a clear commitment to support the fast-growing Chinese market,” said Dr. Schott, Executive Vice President, SCHOTT Glass Tube Division. Patrick Markschlger said, “The plant will introduce SCHOTT's most advanced production technology to further the domestic pharmaceutical industry.” With more than 100 years of experience in the global pharmaceutical packaging industry, SCHOTT will continue to be the pharmaceutical industry in the region. Provide scientific and technical services, as well as provide professional glass technology and regulatory support for pharmaceutical companies in conformity assessment and new drug development.

In view of China's increasing regulatory efforts and increasingly stringent patient safety standards, pharmaceutical companies' demand for high-quality pharmaceutical packaging products is growing steadily. FIOLAX® has been the material of choice for glass packaging materials worldwide since its introduction in 1911. With its uniqueness and good physical and chemical properties, it has been widely used in high quality pharmaceutical packaging containers such as vials, ampoules, cartridges and prefilled syringes.

SCHOTT is a leading international technology group in the field of specialty glass and glass ceramics. The company has accumulated more than 130 years of research and development, materials and technical expertise, and offers a wide range of high quality products and intelligent solutions. SCHOTT is an innovation enabler in a wide range of industries, including home appliances, pharmaceuticals, electronics, optics, life sciences, automotive and aerospace. In improving the quality of people's lives, SCHOTT strives to play an important role and is committed to promoting innovation and sustainable development. SCHOTT has production and sales offices in 33 countries around the world. The company currently employs approximately 15,000 people and had sales of 2.05 billion euros in the 2016/2017 fiscal year. SCHOTT AG, the parent company headquartered in Mainz, Germany, is wholly owned by the Carl Zeiss Foundation. As a fund company, SCHOTT has a special responsibility for its employees, society and the environment.

Disposable Sterile Catheterization Kit

Sterile Catheterization Kit,Disposable Catheterization Kit,Medical Sterile Catheter Kit,Disposable Sterile Catheterization Kit

Xinxiang Huaxi Sanitary Materials Co., Ltd. , https://www.huaximedical.com